A phase II open-label trial of avelumab plus axitinib in previously treated non-small-cell lung cancer or treatment-naïve, cisplatin-ineligible urothelial cancer

G. Galffy, I. Lugowska, E. V. Poddubskaya, B. C. Cho, M. J. Ahn, J. Y. Han, W. C. Su, R. J. Hauke, S. H. Dyar, D. H. Lee, P. Serwatowski, D. L. Estelles, V. R. Holden, Y. J. Kim, V. Vladimirov, Z. Horvath, A. Ghose, A. Goldman, A. di Pietro, J. WangD. A. Murphy, A. Alhadab, M. Laskov

Research output: Contribution to journal › Article › peer-review

4 Citations (Scopus)

Fingerprint

Dive into the research topics of 'A phase II open-label trial of avelumab plus axitinib in previously treated non-small-cell lung cancer or treatment-naïve, cisplatin-ineligible urothelial cancer'. Together they form a unique fingerprint.

Medicine & Life Sciences